NUSINERSEN SODIUM

Nusinersen Sodium Overview

Nusinersen sodium (brand name Spinraza) is a prescription medicine used to treat Spinal Muscular Atrophy, often called SMA. It is given by a specially trained doctor directly into the fluid surrounding the spinal cord. It helps the body produce a necessary protein that keeps muscles and nerves working properly.

Key Facts Summary:

What Is Nusinersen Sodium and How Does It Work?

Nusinersen is a type of medicine called an antisense oligonucleotide. It works by fixing a genetic processing mistake in the body.

Mechanism of Action

People with Spinal Muscular Atrophy are missing a functional main gene called SMN1. This gene tells the body how to make survival motor neuron (SMN) protein, which keeps motor neurons alive. Motor neurons are the nerve cells that control muscle movement. Without sufficient protein, these nerves degenerate, causing progressive muscle weakness.

The body has a backup gene called SMN2, but it usually produces a truncated, unstable version of the protein due to alternative splicing. Nusinersen binds directly to a specific intronic splice silencing site in the pre-mRNA transcript of the SMN2 gene. By altering mRNA splicing, it forces the SMN2 gene to include exon 7 and produce a full-length, functional SMN protein. With increased functional protein levels, motor neurons survive, helping patients maintain or improve physical strength.

Is Nusinersen Sodium FDA Approved?

Yes, Nusinersen is officially approved by the United States Food and Drug Administration. It was the first targeted disease-modifying treatment approved for this condition.

What Is Nusinersen Sodium Used For?

• Treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

Before Taking Nusinersen Sodium: Contraindications and Precautions

Because this medicine is injected into the spinal canal, and because it carries potential risks for blood clotting and kidney function, your medical team will require laboratory testing before every single dose.

Who Should Not Take Nusinersen Sodium?

• There are no absolute contraindications listed for Nusinersen. However, patients with an active infection at or near the lumbar puncture injection site should defer administration until the infection resolves.

Nusinersen Sodium, Pregnancy and Fertility

Discuss your pregnancy plans with your doctor. Animal reproduction studies suggest potential risks to fetal development, though clinical human data remains limited. It is unknown if Nusinersen passes into human breast milk. Discuss the risks and benefits of breastfeeding with your doctor.

Tell Your Doctor Before Taking Nusinersen Sodium

• Disclose any history of bleeding disorders, low blood platelets, or easy bruising.
• Inform your provider if you have a history of kidney disease or renal impairment.
• Share if you take any blood thinners or antiplatelet drugs.
• Provide a complete list of all active prescription drugs and over-the-counter medicines.

Nusinersen Sodium Dosage and Administration

This medicine is not a pill or a regular shot. It must be given in a hospital or specialized clinic by a healthcare professional experienced in performing lumbar punctures (spinal taps).

Standard Nusinersen Sodium Dosing

• Recommended Dosage: The standard individual dose is 12 mg (5 mL) per administration.
• Loading Doses: Treatment begins with four loading doses to rapidly establish therapeutic levels. The first three doses are given 14 days apart (Days 0, 14, and 28). The fourth loading dose is given 30 days after the third dose (Day 63).
• Maintenance Doses: Following the loading phase, a maintenance dose of 12 mg is administered once every 4 months.

How Nusinersen Sodium Is Administered

• Allow the vial to warm to room temperature (not exceeding 30°C/86°F) before administration.
• The doctor removes a volume of cerebrospinal fluid (CSF) equivalent to the dose prior to administration.
• Inject the medication intrathecally over a period of 1 to 3 minutes using a lumbar puncture needle.
• Ultrasound or other imaging guidance may be utilized to assist with injection positioning.

Nusinersen Sodium Clinical Efficacy and Research

FDA approval of Nusinersen was supported by double-blind, sham-procedure controlled clinical trials (such as ENDEAR and CHERISH) in infantile-onset and later-onset SMA patients. In these trials, patients receiving Nusinersen demonstrated statistically significant improvements in motor milestones (such as head control, sitting, and rolling) and event-free survival compared to untreated control groups. Long-term observational studies confirm sustained maintenance or improvements in motor function across age cohorts.

Nusinersen Sodium Side Effects and Safety Profile

While Nusinersen offers significant therapeutic benefit, both the drug and the intrathecal administration procedure carry specific medical risks.

Common Nusinersen Sodium Side Effects

• Lower respiratory tract infections (such as pneumonia or bronchitis).
• Atelectasis and fever.
• Constipation.
• Headache and back pain (often post-lumbar puncture syndrome).
• Vomiting.

Serious Nusinersen Sodium Adverse Events

• Thrombocytopenia and Coagulation Abnormalities: Dangerous drops in blood platelet counts or prolonged clotting times can occur, raising the risk of severe bleeding complications.
• Renal Toxicity: Nusinersen can cause renal injury and severe proteinuria.
• Complications related to lumbar puncture (such as post-dural puncture headache, back pain, or infection).

Managing Nusinersen Sodium Side Effects

Post-lumbar puncture headaches are common; resting flat in a recumbent position and maintaining hydration after the injection helps reduce symptoms. Because of the risk of bleeding and kidney damage, completing all requested laboratory evaluations prior to each dose is essential.

Nusinersen Sodium Drug Interactions and What to Avoid

Nusinersen does not undergo major cytochrome P450 metabolism, making drug-drug metabolic interactions unlikely. However, caution is required regarding agents that affect coagulation.

Nusinersen Sodium Drug-Drug Interactions

• Anticoagulants and Antiplatelet Drugs (Warfarin, Heparin, Plavix, Aspirin): Concomitant use with agents that affect blood clotting increases the risk of bleeding complications during lumbar puncture.
• Nephrotoxic Medications: Concurrent use with other drugs known to cause kidney damage requires enhanced renal monitoring.

Nusinersen Sodium, Food and Alcohol

• There are no specific food or dietary interactions.
• Follow standard pre-procedure fasting or fluid intake instructions provided by your clinical care team.

Nusinersen Sodium Missed Dose, Overdose and Storage

Maintaining schedule adherence ensures adequate continuous intrathecal drug concentrations for SMN protein synthesis.

Missed Dose of Nusinersen Sodium

If a loading dose is delayed, administer it as soon as possible, ensuring at least 14 days separate the doses. If a maintenance dose is delayed, administer it as soon as possible and resume 4-month maintenance intervals from that newly established date.

Nusinersen Sodium Overdose and Emergency

Because this medication is administered solely by trained medical personnel using pre-measured 12 mg vials, an accidental overdose is rare. Supportive monitoring is provided in the event of any administration discrepancy.

How to Store Nusinersen Sodium

• Store vials in a refrigerator between 36°F and 46°F (2°C and 8°C).
• Keep in the original carton to protect from light; do not freeze.
• Unopened vials may be stored at room temperature up to 30°C (86°F) for up to 14 days if refrigeration is unavailable.

Nusinersen Sodium Patient Management and Monitoring

Your medical team will perform specific laboratory screening prior to every administration to manage systemic toxicity risks.

Tests Before Starting And Before Every Dose

• Complete blood count (CBC) including platelet count.
• Coagulation panel (such as PT/INR and aPTT).
• Quantitative spot urine protein test (to screen for renal toxicity).

Monitoring During Nusinersen Sodium Treatment

• Routine neurological and motor function assessments to measure physical milestones.
• Continuous monitoring for signs of lower respiratory tract infections.
• Post-procedure evaluation for signs of CSF leakage, severe headache, or injection site infection.

Nusinersen Sodium Do’s and Don’ts

• DO complete all required blood and urine laboratory tests before every scheduled injection.
• DO report unusual bleeding, petechiae, easy bruising, or dark urine to your doctor immediately.
• DON’T miss or skip scheduled maintenance doses.
• DON’T start taking new over-the-counter NSAIDs or blood thinners without consulting your care team.

Frequently Asked Questions

References

• U.S. FDA prescribing information for Spinraza (Nusinersen) injection
• U.S. FDA Drugs@FDA drug approval overview (Application No. 209531)
• ENDEAR and CHERISH Phase 3 Clinical Trial Results in Spinal Muscular Atrophy

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.